Telemonitoring: A bridge to personalized medicine

Sep 01, 2009

An increasing number of heart failure patients are treated with a number of complex devices, i.e. cardiac resynchronization therapy (CRT). Recently completed and ongoing clinical trials such as MADIT-CRT and EchoCRT provide evidence of a growing number of CRT patients, in need of individualised treatment. Rising demand for implantable cardiac devices and the simultaneous need for increased efficiency as well as enhanced patient comfort and safety significantly increase the need for remote monitoring technology.

Despite the wide availability of telemonitoring systems in many European countries, currently only around 1% of patients with implantable cardiac devices in Europe are being monitored remotely. The majority are still being followed up by conventional in-office follow-up schemes. By the end of 2008, approximately 23.000 European patients were being monitored remotely.

Telemonitoring enables the safe reduction of traditional face to face follow-ups, thereby reducing physicians' workload by focusing on individual patients who need clinical attention. Telemonitoring studies such as TRUST, REFORM and ISMOS have shown that the number of regular in-office medical check-ups can be reduced by about 50% without risking patient's safety.

It also enables early detection of silent, asymptomatic arrhythmias allowing for earlier intervention compared to conventional follow-ups, since all patient data are updated on a daily basis. This facilitates a need-based and individualised patient aftercare, complying with the current HRS/EHRA recommendations and giving patients freedom, mobility, and a sense of relief, knowing that their heart is under continuous surveillance.

Source: European Society of Cardiology (news : web)

Explore further: Medtronic spends $350M on another European deal

add to favorites email to friend print save as pdf

Related Stories

New therapy found to prevent heart failure

Jun 23, 2009

A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) ...

Big disparities in the treatment of arrhythmias across Europe

Jun 21, 2009

The latest statistics regarding the use of pacemakers and implantable cardiac devices in Europe was presented on Sunday 21 June, at EUROPACE 2009, the meeting of the European Heart Rhythm Association (EHRA)1 which takes plac ...

Recommended for you

Medtronic spends $350M on another European deal

11 hours ago

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

Mind over matter for people with disabilities

Aug 26, 2014

People with serious physical disabilities are unable to do the everyday things that most of us take for granted despite having the will – and the brainpower – to do so. This is changing thanks to European ...

Ukraine's former world's tallest man dies

Aug 25, 2014

Ukraine's tallest man, who briefly held the world record but gave it up to live as a recluse, has died due to complications from the condition that saw him never stop growing, local media reported Monday.

User comments : 0